ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expand
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly trea
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325.
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch
Announcement as on 16 March 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2312.48
  • 12Day Average: 2279.4
  • 20Day Average: 2250.82
  • 50Day Average: 2227.79
  • 100Day Average: 2244.84
  • 150Day Average: 2179.47
  • 200Day Average: 2118.64

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2285.39, 2263.09, 14.27
Indicator MACD is in positive zone

Indicator ADX (14)

21.06, 17.62, 11.49
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Tue Aug 2026 2305.00 2305.00 to 2332.90 -1.03% 0.91 times
17 Mon Aug 2026 2329.00 2300.00 to 2337.00 0.46% 0.73 times
14 Fri Aug 2026 2318.40 2307.20 to 2341.60 -0.07% 1.5 times
13 Thu Aug 2026 2320.00 2281.90 to 2322.90 1.31% 0.99 times
12 Wed Aug 2026 2290.00 2272.40 to 2310.00 0.62% 1.11 times
11 Tue Aug 2026 2276.00 2245.00 to 2291.00 1.1% 0.68 times
10 Mon Aug 2026 2251.30 2251.30 to 2297.80 -1.22% 0.62 times
07 Fri Aug 2026 2279.10 2256.00 to 2289.00 0.4% 1.05 times
06 Thu Aug 2026 2270.00 2247.00 to 2290.00 0.49% 1.33 times
05 Wed Aug 2026 2259.00 2202.20 to 2263.30 1.53% 0.93 times
04 Tue Aug 2026 2225.00 2200.00 to 2244.00 -0.22% 1.06 times
03 Mon Aug 2026 2230.00 2162.00 to 2256.40 -0.17% 3.13 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top